TransMedics Group Inc vs Wendys Co — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Wendys Co trades at $7.62 (market cap $1.50B). The key difference: TransMedics Group Inc is the larger of the two by market cap, and Wendys Co pays a 7.13% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TMDX | WEN | |
|---|---|---|
Market Cap | $2.54B | $1.50B |
Sector | Technology | Consumer Cyclical |
52-Week High | $150.42 | $11.33 |
52-Week Low | $61.99 | $6.17 |
Enterprise Value | $2.94B | $5.31B |
Dividend Yield | — | 7.13% |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →